MicroPort CardioFlow Medtech Corporation
HKEX:2160.HK
0.68 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 336.215 | 251.026 | 200.813 | 103.934 | 21.502 | 0 |
| Cost of Revenue
| 106.284 | 88.896 | 82.112 | 58.554 | 15.2 | 0 |
| Gross Profit
| 229.931 | 162.13 | 118.701 | 45.38 | 6.302 | 0 |
| Gross Profit Ratio
| 0.684 | 0.646 | 0.591 | 0.437 | 0.293 | 0 |
| Reseach & Development Expenses
| 237.342 | 223.784 | 151.132 | 96.84 | 96.701 | 44.746 |
| General & Administrative Expenses
| 70.219 | 71.992 | 41.241 | 98.945 | 2.888 | 1.488 |
| Selling & Marketing Expenses
| 223.006 | 160.775 | 116.415 | 51.357 | 26.105 | 9.381 |
| SG&A
| 293.225 | 232.767 | 157.656 | 150.302 | 28.993 | 10.869 |
| Other Expenses
| -0.019 | -10.321 | -1.892 | -16.389 | 4.058 | 4.328 |
| Operating Expenses
| 581.571 | 446.23 | 306.896 | 230.753 | 129.752 | 59.943 |
| Operating Income
| -313.651 | -284.1 | -188.195 | -185.373 | -123.45 | -59.264 |
| Operating Income Ratio
| -0.933 | -1.132 | -0.937 | -1.784 | -5.741 | 0 |
| Total Other Income Expenses Net
| -61.742 | -167.199 | 5.544 | -212.714 | -21.072 | -0.32 |
| Income Before Tax
| -463.582 | -451.299 | -182.651 | -398.087 | -144.522 | -60.263 |
| Income Before Tax Ratio
| -1.379 | -1.798 | -0.91 | -3.83 | -6.721 | 0 |
| Income Tax Expense
| 7.952 | 3.096 | 0.613 | 210.893 | 22.129 | 0.58 |
| Net Income
| -471.534 | -454.395 | -183.264 | -608.98 | -166.651 | -60.263 |
| Net Income Ratio
| -1.402 | -1.81 | -0.913 | -5.859 | -7.75 | 0 |
| EPS
| -0.2 | -0.19 | -0.079 | -0.26 | -131.66 | -0.026 |
| EPS Diluted
| -0.2 | -0.19 | -0.079 | -0.26 | -131.66 | -0.026 |
| EBITDA
| -254.606 | -235.379 | -126.431 | -162.691 | -108.633 | -56.551 |
| EBITDA Ratio
| -0.757 | -0.938 | -0.63 | -1.565 | -5.052 | 0 |